Robert W. Fairbairn, Director at BlackRock Health Sciences Term Trust (BMEZ), sold 20,588 shares at $14.98 ($308K) on 2025-12-18, disclosed to the SEC on 2025-12-22.
Open-market sale of $308k BMEZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.98 | 10,294 | $154K | 50.0% |
| 2 | $14.98 | 10,294 | $154K | 50.0% |
| 3 | $14.96 | 0 | $6 | 0.0% |
| Total | $14.98 avg | 20,588 | $308K | 100% |
| Filing → |
| BSTZ | SELL | 2025-12-22 | $418K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |
| BSTZ | BUY | 2022-02-09 | $497K | — | Filing → |